Introduction
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lead to abnormal development of the whole organism. Sometimes the disorders acquired in childhood cause irreversible effects in adulthood. Therefore, the development of the gastrointestinal tract, especially of the functional digestive organs (e.g., pancreas, stomach and intestine), is an important aspect for the whole organism growth (Chandra and Liddle, 2009 ). Apelin and its apelin receptor APJ are widely expressed in the body (Tatemoto et al., 1998; Hosoya et al., 2000; Medhurst et al., 2003; Kapica et al., 2012) . In the young rats APJ receptor is present in the epithelium, intestinal goblet cells and in smooth muscle cells (Wang et al., 2009 ). In the gastrointestinal tract of young rats the mRNA expression of apelin and APJ receptor is the highest at birth and decreases postnatally (Wang et al., 2009 ). In the postnatal rat stomach, the density of gastric apelin-containing cells increases progressively during weaning and then decreases in the adulthood (Wang et al., 2009) .
Firstly, apelin was isolated from the bovine stomach extracts (Tatemoto et al., 1998) . Now it is known that apelin is present in the body in many bioactive isoforms consisting of 12, 13, 17 or 36 amino acids and in the form of the pyroglutamated apelin-13 (Pyr(1)-apelin-13) (Medhurst et al., 2003) . Apelin-36, apelin-17 and apelin-13 are the predominant molecular forms of endogenous hypothalamic and plasma apelin in rats (De Mota et al., 2000; Kawamata et al., 2001; Castan-Laurell et al., 2011) . On the other hand, Pyr(1)-apelin-13 was found to be a predominant isoform in human cardiac tissue (Maguire et al., 2009 ). All apelin isoforms bind to the apelin receptor APJ (Kawamata et al., 2001 ) that is a 7-transmembrane domain G i -coupled receptor containing 380 amino acids (O'Dowd et al., 1993) .
In adult organism apelin regulates food intake (Taheri et al., 2002) and stimulates cholecystokinin (CCK) secretion (Wang et al., 2009; Castan-Laurell et al., 2011) . It also inhibits the insulin response to intravenous glucose in mice fed high-fat diet (CastanLaurell et al., 2011) . The experiment conducted on IEC-6 cell line showed that apelin suppresses apoptosis, mitosis and DNA repair enzyme 8-oxoguanine (OGG 1/2) expression in the intestinal crypts (Antushevich et al., 2014) . In adult rats apelin exhibited positive effect on the gastrointestinal tract rebuilding and regeneration (Antushevich et al., 2013) , in contrast to young rats (Antushevich et al., 2015) . Apelin occurs in colostrum, milk (Mesmin et al., 2011) and in the lumen of the gastrointestinal tract in young animals (Wang et al., 2009) , which suggests presumable role of this peptide in gastrointestinal tract functioning in young organism. Therefore, the aim of the present study was to investigate the effect of exogenous apelin administrated by different ways on gastric and pancreatic enzymes activity in young rats.
Material and methods

Animals
Two experiments were carried out on weaning male Wistar rats. In the first experiment rats received apelin intragastricly and in the second oneintraperitonealy. Both experiments were approved by the II Local Ethics Committee for the Experiments on Animals in Lublin (Poland), agreement No. 49/2008. The rats were maintained in individual metabolic cages in a temperature controlled room 21 ± 01 °C with a 12 h light/dark cycle (light phase 7:00 -19:00) with free access to standard feed (Labofeed H Standard, Feed Company 'Morawski', Kcynia, Poland) and water. In each experiment the rats (50 ± 10 g of body weight (BW)) were divided into control and experimental group of 6 rats each. Apelin-13 (Hokuriku University, Japan) was given intragastricly (i.g.), using probe Agnthos (Lidingö, Sweden) or intraperitonealy (i.p.), using syringe for insulin injection, in a dose 100 nmol· kg -1 BW twice a day (9:00 and 21:00) for 10 days. Control groups received physiological saline in the corresponding way. Apelin dose was selected on the basis of our previous studies (Kapica et al., 2012; Antushevich et al., 2014) . At the end of experiment, about 12 h after the last apelin-13 administration, the rats were weighed to monitor animal growth and euthanized with carbon dioxide. Blood samples were collected immediately afterwards directly from a heart in a volume of 1 ml for apelin and CCK analysis. The blood samples were preserved using 10% EDTA (Sigma-Aldrich, St. Louise, MO, USA), centrifuged for 10 min at 4500 rpm at 4 °C and obtained plasma was stored at -20 °C. After blood collections the rats were subjected to autopsy and there were no abnormalities in the examined organs observed. The liver, stomach and pancreas were isolated and weighted. Liver was taken for weighting as the organ which plays a key role in the organism detoxification and production of biologically active compounds necessary for digestion, while pancreas and stomach were collected to study their enzymatic activity as in these organs digestive enzymes are produced. Next, the samples of pancreas and stomach tissues were frozen in liquid nitrogen and stored at −80 °C until further assays.
Apelin and CCK concentration in plasma
Total plasma concentration of apelin and CCK was measured by radioimmunoassay (RIA) using a commercially available kits: Apelin-36 (Rat, Mouse) and CCK (Phoenix Pharmaceutical Inc., Karlsruhe, Germany). The used kit for apelin examination is designed to measure overall concentration of apelin in blood because it detects all molecular isoforms of apelin. In the CCK RIA kit a nonsulphated CCK (26-33) octapeptide fragment was used as a standard. Both tests were conducted according to producer's recommendations.
Pancreatic enzymes activity
To evaluate the enzymatic activity, pancreatic samples were homogenized in a lysis buffer and in the obtained homogenates total protein content, and the activities of trypsin, amylase and lipase were analysed. Total protein content was measured using the Lowry method (Lowry et al., 1951) modified to be performed in 96-microwell plates. Trypsin activity was determined by a Trypsin Activity Assay Kit (Bio Vision, Milpitas, CA, USA); -amylase activity was measured by a QuantiChrom™ α-Amylase Assay Kit DAMY-100 (Bioassays Systems, Hayward, CA, USA) and lipase activity was determined using a Lipase-PS kit QuantiChrom™ Lipase Assay Kit (Bioassays Systems, Hayward, CA, USA). Tests were conducted according to the producers' recommendations.
Gastric enzymes activity
For gastric enzymes activity analysis a whole stomach was homogenized in a lysis buffer and in the obtained homogenates total protein, and the activities of pepsin and rennet were analysed. Total protein content was measured by the Lowry method as described above. Pepsin activity was determined according to the Walker method (Walker and Taylor, 1979) . Rennet activity was measured according to Erlanger method using BAPNA (N-α-benzoyl-DL-arginine-p-nitroanilide; SigmaAldrich, St. Louise, MO, USA) as a substrate (Erlanger et al., 1961) .
Statistical analysis
Results are expressed as mean ± standard error of mean (SEM). The Student's t-test was used to indicate the statistical differences between control and experimental group for each experiment separately (Statistica v.10.0, 2011; StatSoft Inc., Tulsa, OK, USA) . In all statistical analyses < 0.05 was taken as the level of significance.
Results
Influence of apelin-13 on the liver, stomach, pancreas and body weight
The intragastric administration of apelin-13 increased ( < 0.001) stomach weight in comparison with the control group. No effect of intragastric and intraperitoneal apelin-13 administration on the liver, pancreas and final body weight was found (Table 1) .
Effect of apelin-13 on the plasma concentration of apelin and CCK
In the young rats i.g. and i.p. administration of apelin-13 increased ( < 0.001) CCK level in blood. On the other hand, neither i.g. nor i.p. treatment with apelin-13 modified the overall plasma level of apelin ( Table 2) .
Influence of apelin-13 on the protein content and activity of pancreatic enzymes
The intragastric administration of apelin-13 increased ( < 0.001) lipase activity in rat pancreatic homogenates by 47% ( Figure 1D ). No effect of i.g. administration of apelin-13 on the total protein content and the activity of trypsin and amylase was observed in comparison with the control group (Figure 1 -A,B,C) . Table 1 . Body and gastrointestinal organs weights of young rats after intragastric and intraperitoneal administration of apelin-13 (100 nmol · kg -1 body weight / twice a day for 10 days) Experiment Weight, g body liver stomach pancreas 1 -intragastric administration control 84.7 ± 13.1 4.3 ± 0.86 0.744 ± 0.07 0.558 ± 0.09 apelin 96.3 ± 9.3 5.1 ± 0.65 0.907 ± 0.09*** 0.520 ± 0.12 2 -intraperitoneal injection control 84.7 ± 12.1 4.7 ± 0.63 0.836 ± 0.11 0.565 ± 0.12 pelin 85.5 ± 7.4 4.6 ± 0.66 0.900 ± 0.05 0.550 ± 0.14 values are given as means ± SEM (n = 6); *** -value significantly different at P < 0.001 values are given as means ± SEM (n = 6); *** -value significantly different at < 0.001
On the other hand, i.p. administration of apelin-13 increased ( < 0.001) all examined parameters in pancreas tissue. In the experimental group the protein content and activities of trypsin and α-amylase were higher by 22, 13 and 33%, respectively, in comparison with the control group (Figure 2 -A,B,C) . But the most pronounced effect was observed on pancreatic lipase activity 159% increase was by in comparison with the control group ( Figure 2D ). 
The effect of apelin-13 administration on the activity of gastric enzymes
In young rats, both i.g. and i.p. administration of apelin-13 exerted no effect on total protein content and the activity of pepsin and rennet in the young rats stomach tissue as compared with the corresponding control groups. After i.g. administration of apelin-13 the values were as follows: protein content 67.6 ± 5.5 mg · g -1 of tissue in the control group and 69.9 ± 5.7 mg · g -1 of tissue in the experimental group; the activity of pepsin 3.1 ± 0.28 U · g -1 of tissue in the control group and 3.5 ± 0.5 U · g -1 of tissue in the experimental group; the activity of rennet 40.6 ± 7.7 U · g -1 of tissue in the control group and 43.0 ± 7.2 U · g -1 of tissue in the experimental group. Similarly, in the experiment which studied the effect of i.p. administration of apelin-13 the values were as follows: protein content 59.4 ± 8.9 mg · g -1 of tissue in the control group and 62.1 ± 6.9 mg · g -1 of tissue in the experimental group; the activity of pepsin 3.34 ± 0.33 U · g -1 of tissue in the control group and 3.02 ± 0.29 U · g -1 of tissue in the experimental group; the activity of rennet 41.3 ± 4.0 U · g -1 of tissue in the control group and 38.6 ± 5.7 U · g -1 of tissue in the experimental group.
Discussion
The obtained results show that neither intraperitoneal (i.p.) nor intragastric (i.g.) administration of apelin influenced the body weight and studied gastrointestinal organs weights except stomach after i.g. administration. We supposed that the increased stomach weight may be connected with apelin indirect action on stomach smooth muscle layer proliferation. Literature data show that apelin-13 can stimulate vascular smooth muscle cell proliferation by promoting the G1-S phase transition, and that this effect is mediated in part by an apelin-pERK1/2-cyclin D1 signal cascade (Li et al., 2008) .
The present study also demonstrates that in young rats i.g. and i.p. administration of apelin-13 increases the level of plasma cholecystokinin (CCK), but has no effect on the overall plasma apelin level. It is known that CCK plays an important role in the mediation of gastrointestinal functions. It exerts effect on the gallbladder contraction which influences bile salts secretion and also increases blood flow and pancreatic enzymes secretion. CCK has also influence on duodenal secretion, satiety, insulin secretion and glucose homoeostasis (Rehfeld, 1989) . Increased CCK concentration in blood in our experiment may be connected with stimulating actions of apelin on neurohormonal mediators and neurotransmitters, which activates CCK secretion. It was also previously found that regulatory peptides including apelin (Wang et al., 2009) , leptin (Sobhani et al., 2002) , ghrelin (Kapica et al., 2006; Nawrot-Porąbka et al., 2007) and obestatin (Kapica et al., 2007) when secreted into the gastric lumen, may reach the intestinal lumen and stimulate CCK secretion (Zabielski et al., 1998) . In studies it was observed that apelin stimulated CCK secretion from a murine enteroendocrine cell line by mitogen-activated protein kinase (MAPK) pathway. Apelin also caused CCK release from dispersed intestinal endocrine cells and proximal small intestine cells (Lv et al., 2013) . No effect of experimental treatment on the plasma level of apelin may be due to the short half-life (about 8 min) of plasma apelin (Aydin et al., 2014) . In the presented experiment the blood was collected 12 h after the last apelin administration. We did not collect blood samples intravitally, because the procedure of blood taking is very stressful for young rat.
We also noticed that neither i.p. nor i.g. administration of apelin had an effect on the gastric pepsin and rennet activity. Our previous study showed that i.g. and i.p. administration of apelin-13 in the stomach increased the number of cells expressing the enzyme 8-oxoguanine glycosylase (OGG 1/2) indicating DNA damage in the cells (Antushevich et al., 2015) . Such data allow us to suppose that the lack of apelin effect on gastric enzymes secretion may be connected with increased damage of cells responsible for secretion of pepsin and rennet in stomach.
Our present data also show that the i.p. administration of apelin-13 stimulates total protein content and the activity of all studied pancreatic enzymes (trypsin, α-amylase and lipase), whereas the i.g. administration of apelin-13 rats stimulates only the activity of pancreatic lipase. The mechanism of apelin action on the gastrointestinal enzyme secretion is still unknown. Pancreatic juice secretion is regulated by endocrine, paracrine and neuronal interactions involving several regulatory peptides and neurotransmitter secreted in the gut (Holst et al., 1984; Sheikh et al., 1988; Dunning et al., 1990; Novak, 2003; Lee et al., 2012) . However, the secretory function of pancreas in young individuals is insufficient. The lack of i.g. apelin-13 administration effect on the pancreatic enzymes activity (except lipase) obtained in the present study might be related to the lack of fully developed neurohormonal mechanisms or weak enteric nervous system development in young organism. Kapica et al. (2012) , who studied the effect of apelin administration on the pancreato-biliary juice secretion, demonstrated that intravenous injection of apelin reduced pancreato-biliary juice volume and pancreatic output while the intraduodenal boluses of apelin led to the dose-dependent stimulation of pancreatic juice volume and protein output. In turn in experiment conducted on dispersed acinar cells obtained from rat pancreas, the highest dose of apelin-13 (10 -6 M) stimulated basal and CCK-8-stimulated amylase release, whereas its lower doses (10 -7 -10 -8 M) were ineffective (Kapica et al., 2012) . The impact of other regulatory peptides synthetized in stomach on pancreatic secretion is also depended on the way of their administration. Leptin or ghrelin given intravenously reduced pancreatic secretion, but given intraduodenally caused the opposite effect (Kapica et al., 2008) . Stimulatory action of i.p. administrated apelin may be connected with circulating apelin influence on other biologically active compounds in blood which activate signalling pathways involved in the pancreatic enzymes secretion. In this study the observed effect of apelin on CCK secretion can explain increased lipase activity in young rats. The fact that apelin treatment stimulated the lipase activity in young rats suggests that apelin may influence the process of lipids digestion. Lipase is an enzyme that hydrolyses lipids forming fatty acids and glycerol. It is known that milk lipids provides about 40 -60% energy demand for young animals therefore the increased pancreatic lipase activity in young rats after apelin administration may be connected with physiological need to digest milk lipids to provide the energy necessary for growth. Moreover, it was shown that in human apelin content in milk is higher than in colostrum, which is accompanied by an increased milk fat content (Aydin, 2010) . Also, in our earlier studies in the same experimental arrangement conducted only on adult rats, the stimulatory effect of apelin-13 on the activity of lipase was found (Antushevich et al, 2016 ). In the above mentioned experiment, rats with removed main part of stomach producing apelin were also examined. It was observed that fundectomized rats exhibited the decreased apelin and CCK levels and pancreatic enzymes activity, which may confirm the of apelin in food digestibility. Such observation could suggest that apelin supplementation can be useful in patients with gastrointestinal diseases, however further studies in this field are needed. Higuchi et al. (2007) also stated that apelin participates in regulation of body adiposity. They showed in the experiment conducted on mice that daily i.p. apelin injections for 2 weeks decreased the triglycerides content in adipose tissue and the weight of different fat depots in both control and high-fat fed mice.
Conclusions
Circulating apelin exerts the most pronounced effect on pancreatic enzymes activity in young rats, but neither circulating nor luminal apelin has an effect on gastric enzymes activity. Regardless the route of administration apelin increases plasma CCK and pancreatic lipase activity suggesting a considerable role of apelin in the regulation of fat digestion. However, further studies are necessary to explain the mechanism of apelin action on lipid metabolism in young animals.
